Sayantani Sarkar

Title: Sayantani Sarkar: Innovator in Cancer Treatment

Introduction

Sayantani Sarkar is a notable inventor based in Kolkata, India. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on the isolation of organic compounds that have potential therapeutic effects against various types of cancer.

Latest Patents

Sayantani Sarkar holds a patent for a process that isolates organic compounds useful for the treatment of cancer. The patent specifically addresses two main components, mahanine and mahanimbine (dehydroxy-mahanine), which are effective against glioblastoma and cervical carcinoma. Mahanimbine has demonstrated anti-cancer activity against several types of cancer, including lymphoid leukemia, myeloid leukemia, glioma, cervical carcinoma, pancreatic, colon, and lung cancers. The compounds target the chaperone Hsp90, leading to the degradation of various Hsp90-client proteins, which ultimately kills cancer cells. Additionally, mahanine has been shown to reduce the doses of cisplatin and paclitaxel in cervical cancer, enhancing efficacy and reducing toxicity.

Career Highlights

Sayantani Sarkar is affiliated with the Council of Scientific and Industrial Research, where she continues her research in cancer therapeutics. Her innovative approach has led to the establishment of a new, cost-effective process for preparing the active compounds, making significant strides in cancer treatment.

Collaborations

Some of her notable coworkers include Chitra Mandal and Bikas Chandra Pal, who have collaborated with her on various research projects.

Conclusion

Sayantani Sarkar's contributions to cancer treatment through her innovative research and patent demonstrate her commitment to advancing medical science. Her work not only highlights the potential of organic compounds in oncology but also paves the way for more effective and less toxic cancer therapies.